Company Search:
Advanced Search
Sponsored Links
Tetraphase Pharmaceuticals Inc Company Snapshot
Tetraphase Pharmaceuticals Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tetraphase Pharmaceuticals Inc with three other companies in this sector in the United States: Athersys, Incorporation (2015 sales of $11.95 million of which 100% was Biopharmaceutical), Onconova Therapeutics Inc ($11.46 million of which 100% was Identification and), and ArQule, Inc. ($11.24 million of which 100% was Chemical Compounds).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Tetraphase Pharmaceuticals Inc
  Stock Performance Chart for Tetraphase Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 3.97
(Figures in U.S. Dollars)
1 Week 17.1%   13 Weeks 3.7%  
4 Weeks -2.7%   52 Weeks -55.0%  
Tetraphase Pharmaceuticals Inc Key Data:
  Ticker: TTPH Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 11,686,000
(Year Ending Jan 2016).
Employees: 33
  Currency: U.S. Dollars Market Cap: 145,693,283
  Fiscal Yr Ends: December Shares Outstanding: 36,698,560
  Share Type: Common Closely Held Shares: 192,773
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.